Shiqin Cong
Key Laboratory Of Drug Targeting And Drug Delivery System Of The Education Ministry And Sichuan Province
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Design and synthesis of 6-benzyloxybenzo[c]thiophen-1(3H)-ones as selective monoamine oxidase-B inhibitors with antioxidant and anti-neuroinflammatory activities against Parkinson's disease.
Journal: European journal of medicinal chemistry
Published: June 27, 2026
The Pyrazolone Scaffold: A Privileged Motif for Molecular Hybridization in Drug Discovery.
Journal: ChemMedChem
Published: June 13, 2026
Discovery of 3-benzyloxy-6-arylpyridazine derivatives as novel multi-target agents toward Parkinson's disease therapy.
Journal: European journal of medicinal chemistry
Published: January 03, 2026
Benzylpiperidine-pyridazin-3(2H)-one derivatives as potential multifunctional agents against Alzheimer's disease.
Journal: European journal of medicinal chemistry
Published: September 17, 2025
Synthesis and evaluation of butylphthalide-scutellarein hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Journal: European journal of medicinal chemistry
Published: November 05, 2023
Discovery of novel 5-(2-hydroxyphenyl)-2-phthalide-3(3H)-pyrazolones as balanced multifunctional agents against Alzheimer's disease.
Journal: European journal of medicinal chemistry
Published: January 06, 2023
Discovery of novel 3-butyl-6-benzyloxyphthalide Mannich base derivatives as multifunctional agents against Alzheimer's disease.
Journal: Bioorganic & medicinal chemistry
Published: December 14, 2021
6-Benzyloxyphthalides as selective and reversible monoamine oxidase B inhibitors with antioxidant and anti-neuroinflammatory activities for Parkinson's disease treatment.
Journal: Bioorganic chemistry
Published: November 10, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026